Related Experiment Video
Updated: Aug 18, 2026
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Rapid screening method for detection of bacteria in platelet concentrates
Insights
Bacterial contamination in platelet concentrates poses a significant transfusion risk. A new rapid screening method detects bacteria in under 90 minutes, enhancing patient safety.
Area of Science:
- Blood Transfusion Safety
- Microbiology
- Medical Diagnostics
Background:
- Bacterial contamination of blood products, particularly platelet concentrates, presents a serious risk of transfusion-associated sepsis.
- This risk is often underestimated compared to viral transmission, with significant morbidity and mortality rates.
- Current screening methods are insufficient, highlighting the need for rapid and sensitive detection techniques.
Purpose of the Study:
- To develop and describe a novel, rapid, and highly sensitive method for screening bacteria in platelet concentrates.
- To improve patient safety by enabling routine testing of platelet products before transfusion.
Main Methods:
- A multi-stage process involving selective platelet removal via monoclonal antibody-activated filtration.
- DNA-specific fluorescent labeling for bacterial identification.
- Concentration of bacteria on a membrane for enumeration using solid-phase cytometry.
Main Results:
- The developed method provides results in under 90 minutes, eliminating the need for culture periods.
- It offers universal detection of both live and dead Gram-negative and Gram-positive bacteria.
- Achieves a high sensitivity with a detection limit of 10 to 10(2) CFU/ml, surpassing existing culture-based methods.
Conclusions:
- This new method represents a significant advancement in ensuring the safety of platelet concentrate transfusions.
- Its speed, sensitivity, and broad detection capabilities address the critical need for routine bacterial screening.
- Implementation of this technology can substantially reduce the incidence of transfusion-associated sepsis.
Abstract:
Public awareness has long focused on the risks of the transmission of viral agents through blood product transfusion. This risk, however, pales in comparison to the less publicized danger associated with the transfusion of blood products contaminated with bacteria, in particular, platelet concentrates. Up to 1,000 cases of clinical sepsis after the transfusion of platelet concentrates are reported annually in the United States. The condition is characterized by acute reaction symptoms and the rapid onset of septicemia and carries a 20 to 40% mortality rate. The urgent need for a method for the routine screening of platelet concentrates to improve patient safety has long been recognized. We describe the development of a rapid and highly sensitive method for screening for bacteria in platelet concentrates for transfusion. No culture period is required; and the entire procedure, from the time of sampling to the time that the final result is obtained, takes less than 90 min. The method involves three basic stages: the selective removal of platelets by filtration following activation with a monoclonal antibody, DNA-specific fluorescent labeling of bacteria, and concentration of the bacteria on a membrane surface for enumeration by solid-phase cytometry. The method offers a universal means of detection of live, nondividing, or dead gram-negative and gram-positive bacteria in complex cellular blood products. The sensitivity is higher than those of the culture-based methods available at present, with a detection limit of 10 to 10(2) CFU/ml, depending upon the bacterial strain.
